218162-93-7

Upstream product

• 95646-05-2 3(S)-<(tert-butyldiphenylsilyl)oxy>-1,2-bis-O-(isopropylidene)-5(Z)-undecene-1,2(R)-diol 
• 93292-41-2 2-deoxy-3-O-(tert-butyldiphenylsilyl)-4,5-O-isopropylidene-D-erythro-pentose diethyl dithioacetal 
• 93292-42-3 2-deoxy-3-O-(tert-butyldiphenylsilyl)-4,5-bis-O-(1-methylethylidene)-D-erythro-pentose 
• 100428-41-9 2(S)-<(tert-butyldiphenylsilyl)oxy>-4(Z)-decenal 
• 218162-92-6 ethyl-4(S)-<(tert-butyldiphenylsilyl)oxy>-2(E),6(Z)-dodecadienoate 

Downstream Products

• 218162-94-8 methyl-5,5-(dimethylenedithio)-12(S)-<(tert-butyldiphenylsilyl)oxy>-6(E),10(E),14(Z)-eicosatetraenoate 

Relevant academic research and scientific papers

The total synthesis of 5-oxo-12(s)-hydroxy-6(e),8(z),10(e),14(z)- eicosatetraenoic acid and its 8,9-trans-isomer and their identification in human platelets

The first total synthesis of 5-oxo-12(S)-hydroxy-6(E),8(Z),10(E), 14(Z)- eicosatetraenoic acid (5-oxo-12-HETE) 6 and its 8-trans-isomer 7 is reported. The synthetic 5-oxo-12-HETE 6 and its 8,9-trans-isomer 7 were used to identify their formation in mixtures of platelets and neutrophils by transcellular metabolism.